Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Seijen, Maartje"" wg kryterium: Autor


Wyświetlanie 1-19 z 19
Tytuł :
Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen
Autorzy :
van Seijen, MaartjeAff1, Aff2
Brcic, Luka
Gonzales, Atilio Navarro
Sansano, Irene
Bendek, MatyasAff6, Aff7
Brcic, Iva
Lissenberg-Witte, Birgit
Korkmaz, H. Ibrahim
Geiger, Thomas
Kammler, Rosita
Stahel, RolfAff9, Aff10
Thunnissen, Erik
On behalf of ETOP
Pokaż więcej
Źródło :
Virchows Archiv: European Journal of Pathology. 475(2):191-199
Czasopismo naukowe
Tytuł :
Variability in grading of ductal carcinoma in situ among an international group of pathologists.
Autorzy :
Seijen, Maartje
Jóźwiak, Katarzyna
Pinder, Sarah E
Hall, Allison
Krishnamurthy, Savitri
Thomas, Jeremy SJ
Collins, Laura C
Bijron, Jonathan
Bart, Joost
Cohen, Danielle
Ng, Wen
Bouybayoune, Ihssane
Stobart, Hilary
Hudecek, Jan
Schaapveld, Michael
Thompson, Alastair
Lips, Esther H
Wesseling, Jelle
Pokaż więcej
Temat :
CARCINOMA in situ
DUCTAL carcinoma
PATHOLOGISTS
PROGNOSIS
CONFIDENCE intervals
Źródło :
Journal of Pathology: Clinical Research; May2021, Vol. 7 Issue 3, p233-242, 10p
Terminy geograficzne :
GREAT Britain
NETHERLANDS
Czasopismo naukowe
Tytuł :
Feasibility of Micro–Computed Tomography Imaging for Direct Assessment of Surgical Resection Margins During Breast-Conserving Surgery
Autorzy :
Janssen, Natasja N. Y.
van Seijen, Maartje
Loo, Claudette E.
Vrancken Peeters, Marie-Jeanne T. F. D.
Hankel, Tara
Sonke, Jan-Jakob
Nijkamp, Jasper
Pokaż więcej
Temat :
Breast-conserving surgery
Intraoperative margin assessment
Micro-CT
Surgical resection margins
Surgery
Źródło :
Journal of Surgical Research, 241, 160 - 169. Academic Press Inc.
Tytuł :
Prognostic value of residual disease after neoadjuvant therapy in HER2-positive breast cancer evaluated by residual cancer burden, neoadjuvant response index, and Neo-BioSCore
Autorzy :
Steenbruggen, Tessa G.
van Seijen, Maartje
Janssen, Liselore M.
van Ramshorst, Mette S.
van Werkhoven, Erik
Vrancken Peeters, Marie-Jeanne T. D. F.
Wesseling, Jelle
Lips, Esther H.
Sonke, Gabe S.
Pokaż więcej
Temat :
no
skin and connective tissue diseases
Źródło :
Clinical Cancer Research, 25(16), 4985 - 4992. American Association for Cancer Research Inc.
Tytuł :
Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen
Autorzy :
van Seijen, Maartje
Brcic, Luka
Gonzales, Atilio Navarro
Sansano, Irene
Bendek, Matyas
Brcic, Iva
Lissenberg-Witte, Birgit
Korkmaz, H Ibrahim
Geiger, Thomas
Kammler, Rosita
Stahel, Rolf
Thunnissen, Erik
ETOP, ?
Pokaż więcej
Temat :
Clinic for Oncology and Hematology
610 Medicine & health
Źródło :
van Seijen, Maartje; Brcic, Luka; Gonzales, Atilio Navarro; Sansano, Irene; Bendek, Matyas; Brcic, Iva; Lissenberg-Witte, Birgit; Korkmaz, H Ibrahim; Geiger, Thomas; Kammler, Rosita; Stahel, Rolf; Thunnissen, Erik; ETOP, ? (2019). Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen. Virchows Archiv, 475(2):191-199.
Tytuł :
Variability in grading of ductal carcinoma in situ among an international group of pathologists.
Autorzy :
van Seijen M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Jóźwiak K; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Pinder SE; Comprehensive Cancer Centre at Guy's Hospital, School of Cancer & Pharmaceutical Sciences, Kings College London, London, UK.; Department of Cellular Pathology, Guy's and St Thomas' NHS Foundation Trust London, London, UK.
Hall A; Department of Pathology, Duke University Medical Center, Durham, NC, USA.
Krishnamurthy S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Thomas JS; Department of Pathology, Western General Hospital, Edinburgh, UK.
Collins LC; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Bijron J; Department of Pathology, Martini Hospital, Groningen, The Netherlands.
Bart J; Department of Pathology, Isala Hospital, Zwolle, The Netherlands.; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Cohen D; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Ng W; Department of Cellular Pathology, Guy's and St Thomas' NHS Foundation Trust London, London, UK.
Bouybayoune I; Comprehensive Cancer Centre at Guy's Hospital, School of Cancer & Pharmaceutical Sciences, Kings College London, London, UK.
Stobart H; Independent Cancer Patients' Voice, London, UK.
Hudecek J; Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Schaapveld M; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Thompson A; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Isala Hospital, Zwolle, The Netherlands.
Pokaż więcej
Corporate Authors :
Grand Challenge PRECISION consortium.
Źródło :
The journal of pathology. Clinical research [J Pathol Clin Res] 2021 May; Vol. 7 (3), pp. 233-242. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
Autorzy :
Hudeček J; 1Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Voorwerk L; 2Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Seijen M; 3Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nederlof I; 2Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
de Maaker M; 3Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van den Berg J; 4Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van de Vijver KK; 5Department of Pathology, Ghent University Hospital, Ghent, Belgium.
Sikorska K; 6Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Adams S; 7Department of Medicine, Perlmutter Cancer Center, New York University School of Medicine, New York, NY USA.
Demaria S; 8Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA.; 9Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY USA.
Viale G; 10International Breast Cancer Study Group Central Pathology Office, Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.; 11University of Milan, Milan, Italy.
Nielsen TO; 12Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC Canada.
Badve SS; 13Department of Pathology and Laboratory Medicine, Indiana University Simon Cancer Center, Indianapolis, IN USA.
Michiels S; 14Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Université-Paris Sud, Université Paris-Saclay, Villejuif, France.; 15CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Symmans WF; 16Department of Pathology, M.D. Anderson Cancer Center, Houston, TX USA.
Sotiriou C; 17Breast Cancer Translational Research Laboratory, Institut Jules Bordet, U-CRC, Université Libre de Bruxelles, Brussels, Belgium.
Rimm DL; 18Department of Pathology, Yale School of Medicine, New Haven, CT USA.; 19Department of Medicine, Yale University School of Medicine, New Haven, CT USA.
Hewitt SM; 20Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD USA.
Denkert C; 21Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.; 22Institute of Pathology, Philipps-University Marburg, Marburg, Germany.
Loibl S; 23German Breast Group, Neu-Isenburg, Germany.
Loi S; 24Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.
Bartlett JMS; 25Ontario Institute for Cancer Research, Toronto, ON Canada.; 26IGMM, Edinburgh, UK.; 27Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK.
Pruneri G; 28Department of Pathology and Laboratory Medicine, IRCCS Fondazion - Instituto Nazionale Tumori, Milan, Italy.; 29School of Medicine, University of Milan, Milan, Italy.
Dillon DA; 30Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA USA.
Cheang MCU; 31Clinical Trials and Statistics Unit, The Institute of Cancer Research, Surrey, UK.
Tutt A; 32Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Hall JA; Research and Development, Vivactiv Ltd, Chesham, Buckinghamshire UK.
Kos Z; 34Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON Canada.
Salgado R; 24Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium.
Kok M; 2Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; 36Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Horlings HM; 3Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; 4Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Corporate Authors :
International Immuno-Oncology Biomarker Working Group
Źródło :
NPJ breast cancer [NPJ Breast Cancer] 2020 May 12; Vol. 6, pp. 15. Date of Electronic Publication: 2020 May 12 (Print Publication: 2020).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Feasibility of Micro-Computed Tomography Imaging for Direct Assessment of Surgical Resection Margins During Breast-Conserving Surgery.
Autorzy :
Janssen NNY; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: .
van Seijen M; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Loo CE; Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Vrancken Peeters MTFD; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Hankel T; Department of Technical Medicine, University of Twente, Enschede, the Netherlands.
Sonke JJ; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Nijkamp J; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Pokaż więcej
Źródło :
The Journal of surgical research [J Surg Res] 2019 Sep; Vol. 241, pp. 160-169. Date of Electronic Publication: 2019 Apr 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Margins of Excision*
Mastectomy, Segmental*
Breast/*diagnostic imaging
Breast Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Breast/pathology ; Breast/surgery ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/pathology ; Feasibility Studies ; Female ; Humans ; Middle Aged ; Netherlands ; Observer Variation ; Postoperative Period ; Prospective Studies ; Retrospective Studies ; Sensitivity and Specificity ; X-Ray Microtomography
Czasopismo naukowe
Tytuł :
Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen.
Autorzy :
van Seijen M; Department of Pathology, Amsterdam University Medical Centers, VU University Medical Center, Amsterdam, The Netherlands.; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Brcic L; Institute of Pathology, Medical University of Graz, Graz, Austria.
Gonzales AN; Valencia Hospital General Universitario, Valencia, Spain.
Sansano I; Vall d'Hebron University Hospital Barcelona, Spain, Barcelona, Spain.
Bendek M; National Institute of Pulmonary Medicine Budapest, Budapest, Hungary.; Department of Pathology, Karolinska University Hospital, Stockholm, Sweden.
Brcic I; Institute of Pathology, Medical University of Graz, Graz, Austria.
Lissenberg-Witte B; Department of Epidemiology and Biostatistics, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.
Korkmaz HI; Department of Pathology, Amsterdam University Medical Centers, VU University Medical Center, Amsterdam, The Netherlands.
Geiger T; ETOP Bern, Bern, Switzerland.
Kammler R; ETOP Bern, Bern, Switzerland.
Stahel R; ETOP Bern, Bern, Switzerland.; University Hospital of Zurich, Zurich, Switzerland.
Thunnissen E; Department of Pathology, Amsterdam University Medical Centers, VU University Medical Center, Amsterdam, The Netherlands. .
Pokaż więcej
Corporate Authors :
ETOP
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2019 Aug; Vol. 475 (2), pp. 191-199. Date of Electronic Publication: 2019 Jul 01.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*analysis
Carcinoma, Non-Small-Cell Lung/*pathology
Immunohistochemistry/*methods
Lung Neoplasms/*pathology
Tissue Fixation/*methods
Humans ; Staining and Labeling/methods
Czasopismo naukowe
    Wyświetlanie 1-19 z 19

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies